|
gptkbp:instanceOf
|
gptkb:company
|
|
gptkbp:acquiredBy
|
acquired by Valeant Pharmaceuticals in 2013
|
|
gptkbp:foundedBy
|
gptkb:Henry_Lomb
gptkb:John_Jacob_Bausch
|
|
gptkbp:foundedYear
|
1853
|
|
gptkbp:headquartersLocation
|
gptkb:Rochester,_New_York,_United_States
|
|
gptkbp:industry
|
pharmaceuticals
medical devices
eye health
|
|
gptkbp:notableProduct
|
gptkb:Boston
gptkb:Biotrue
gptkb:Ocuvite
gptkb:PreserVision
gptkb:PureVision
gptkb:Renu
|
|
gptkbp:numberOfEmployees
|
~12,000
|
|
gptkbp:parentCompany
|
gptkb:Bausch_Health_Companies
|
|
gptkbp:products
|
pharmaceuticals
contact lenses
eye surgery products
lens care products
|
|
gptkbp:publiclyTraded
|
yes
|
|
gptkbp:rebrandedParentCompany
|
Valeant Pharmaceuticals renamed to Bausch Health Companies
|
|
gptkbp:servesArea
|
worldwide
|
|
gptkbp:stockExchange
|
gptkb:NYSE
|
|
gptkbp:stockSymbol
|
gptkb:BLCO
|
|
gptkbp:type
|
public
|
|
gptkbp:website
|
https://www.bausch.com/
|
|
gptkbp:bfsParent
|
gptkb:Bausch_Health_Companies
gptkb:Costco_Optical
gptkb:Carsten_Brunn
|
|
gptkbp:bfsLayer
|
6
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Bausch + Lomb
|